Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano
1.
Diabetes Technology and Therapeutics ; 24(SUPPL 1):A223, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-1896132

RESUMO

Background and Aims: People with type 1 diabetes (PWT1D) using flash glucose monitoring (FGM) showed no deleterious effect or even an improvement on glycemic control during COVID-19 lockdown. The aim is to assess the impact on glycemic control after 8 weeks and one year after lockdown. Methods: Observational retrospective study in PWT1D using FreeStyle Libre®. Glucometric data from the 2 weeks before lockdown start (PRE) were compared with data of the last 14 days after 8 weeks of consecutive lockdown (POST), and last 14 days one year after lockdown (1 YEAR POST). Results: Data from 287 patients were analyzed (median age 45,5±12,6 years, 50,2% male (n = 144), median diabetes duration 20,5±12,1 years). Median lockdown time was 53,9±4,4 days. Conclusions: PWT1D using FGM monitoring during COVID- 19 pandemic in our clinic showed an improvement in glycemic metrics which was sustained 1 year after lockdown.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA